|
TP2116 |
SAH-SOS1A
|
|
|
|
KRas/son of sevenless 1 (SOS1) interaction inhibitor. Binds within nucleotide binding pocket of KRas (Kd values are 106 - 176 nM for wild type KRas and various KRas mutants). Inhibits nucleotide binding to KRas in a conc... |
|
TP2115 |
SAH-EZH2
|
|
|
|
EZH2/EPP interaction inhibitor (Kd = 320 nM). Suppresses EZH2 expression and H3K27 trimethylation by PCR2 complex. Arrests proliferation and induces monocyte to macrophage differentiation of MLL-AF9 leukemia cell line. |
|
T27056 |
CN-SAH
|
CNSAH |
|
|
CN-SAH is a potent and selective inhibitor of DOT1L. |
|
T76059 |
SAH-SOS1A TFA
|
|
|
|
SAH-SOS1A TFA is a peptide-based SOS1/KRAS protein interaction inhibitor. SAH-SOS1A TFA binds to wild-type and mutant KRAS (G12D, G12V, G12C, G12S, and Q61H) with nanomolar affinity ( EC 50 =106-175 nM). SAH-SOS1A TFA di... |
|
T21902 |
ML351
|
|
Lipoxygenase
|
|
ML351 is a potent and selective inhibitor of human 15-lipoxygenase-1 (15 LOX)(IC50: 200 nM). |
|
T11285 |
FIDAS-5
|
|
Others
|
|
FIDAS-5, a potent and orally active methionine S-adenosyltransferase 2A (MAT2A) inhibitor with an IC50 of 2.1 μM, competitively inhibits S-adenosylmethionine (SAM) binding to MAT2A. It exhibits anticancer activities. |
|
T11284 |
FIDAS-3
|
|
Others
,
Wnt/beta-catenin
,
Methionine Adenosyltransferase (MAT)
|
|
FIDAS-3, a stilbene derivative and potent Wnt inhibitor with an IC50 of 4.9 μM for methionine S-adenosyltransferase 2A (MAT2A), exhibits anticancer activities by effectively competing with S-adenosylmethionine (SAM) for ... |
|
T12908 |
SIBA
|
5'-Deoxy-5'-isobutylthioadenosine,5'-Isobutylthioadenosine |
Nucleoside Antimetabolite/Analog
,
HSV
|
|
SIBA (5'-Deoxy-5'-isobutylthioadenosine) is a synthetic analogue of SAH, acts as an inhibitor of S-adenosylmethionine-mediated transmethylation. SIBA can interfere with a variety of enzymatic activities in vitro, such as... |
|
T11571 |
HLY78
|
4-Ethyl-5-methyl-5,6-dihydro-[1,3]dioxolo[4,5-j]phenanthridine |
Wnt/beta-catenin
|
|
HLY78 (4-Ethyl-5-methyl-5,6-dihydro-[1,3]dioxolo[4,5-j]phenanthridine) targets the DIX domain of Axin, is an activator of the Wnt/β-catenin signaling pathway and can enhance Axin-LRP6 binding to promote Wnt signaling. |
|
T8800 |
NSAH
|
2-hydroxy-N'-[(E)-(2-hydroxynaphthalen-1-yl)methylidene]benzohydrazide |
DNA/RNA Synthesis
|
|
NSAH (2-hydroxy-N'-[(E)-(2-hydroxynaphthalen-1-yl)methylidene]benzohydrazide) is a nonnucleoside inhibitor of human ribonucleotide reductase (hRR).with cell-free IC50 of 32 μM and cell-based IC50 of ~250 nM, respectively... |
|
T19294 |
Docosahexaenoic Acid methyl ester
|
Methyl docosahexaenoate,all cis-DHA methyl ester |
Others
|
|
Docosahexaenoic Acid methyl ester (all cis-DHA methyl ester) is a methylated docosahexaenoic acid analog that can be inserted into membrane phospholipids without being oxidized or hydrolyzed. |
|
T71011 |
Perfluorinated SAHA
|
|
|
|
Perfluorinated SAHA is an HDAC inhibitor for use in cancer treatment regimens, with demonstrated greater antiproliferative properties than SAHA . PFSAHA has also been shown to have higher selectivity for PA3774, an HDAC-... |
|
T73454 |
SAHA-OH
|
|
HDAC
|
|
SAHA-OH, a selective HDAC6 inhibitor with an IC50 of 23 nM, exhibits a 10- to 47-fold greater selectivity for HDAC6 over HDACs 1, 2, 3, and 8. It demonstrates anti-inflammatory effects and reduces macrophage apoptosis [1... |
|
T37532 |
Docosahexaenoyl Glycine
|
|
|
|
The ω-3 polyunsaturated fatty acids (PUFAs) found in fish oils provide cardiovascular benefits. Docosahexaenoic acid (DHA), a C22:6 PUFA, is the most abundant ω-3 fatty acid in neural tissues, especially in the retina an... |
|
T35765 |
SAHA-BPyne
|
|
|
|
Suberoylanilide hydroxamic acid (SAHA) is a class I and class II histone deacetylase (HDAC) inhibitor that binds directly to the catalytic site of the enzyme thereby blocking substrate access. SAHA-BPyne is a SAHA deriva... |
|
T74757 |
Didocosahexaenoin
|
|
|
|
Didocosahexaenoin, an omega-3 derivative and diglyceride of DHA synthesized from DHA triglycerides, significantly decreases mitochondrial membrane potential and stimulates ROS (reactive oxygen species) production. It ind... |
|
T77230 |
1-O-Hexadecyl-2-O-docosahexaenoyl-sn-glycero-3-phosphorylcholine
|
|
|
|
1-O-Hexadecyl-2-O-docosahexaenoyl-sn-glycero-3-phosphorylcholine, an endogenous metabolite found in urine, has applications in obesity research [1] [2]. |
|
T36868 |
4-oxo Docosahexaenoic Acid
|
|
|
|
4-oxo Docosahexaenoic acid (4-oxo DHA) is a putative metabolite of DHA with antiproliferative and PPARγ agonist activity. It inhibits the growth of several triple negative breast cancer cell lines (MCF-10F, trMCF, bsMCF,... |
|
T76054 |
SAHM1 TFA
|
|
|
|
SAHM1 TFA is a chemical compound that acts as a Notch pathway inhibitor by stabilizing a hydrocarbon-stapled alpha helical peptide. It specifically targets the protein-protein interface, effectively preventing the assemb... |
|
T38028 |
(R)-(+)-Docosahexaenyl-1'-Hydroxy-2'-Propylamide
|
|
|
|
N-Acyl ethanolamines (NAEs) have diverse biological actions that are strongly affected by the associated acyl group. Docosahexaenoyl ethanolamide (DHEA) has potential signaling roles in cancer, inflammation, and neurolog... |
|
T35767 |
SAHO2
|
|
|
|
SAHO2is a sulfone form of the methyl donor S-(5'-adenosyl)-L-methionine chloride and is a substrate for radical SAM enzymes.1It is reductively cleaved to 5'-deoxyadenosine and 5'-thioadenosine sulfinic acid by the radica... |
|
T21749 |
4-iodo-SAHA
|
|
|
|
4-Iodo-SAHA (1k), an orally active inhibitor of both class I and class II histone deacetylase (HDAC), exhibits EC50 values of 1.1, 0.95, 0.12, 0.24, 0.85, and 1.3 μM for Skbr3, HT29, U937, JA16, and HL60 cell lines, resp... |
|
T38218 |
1-Stearoyl-2-docosahexaenoyl-sn-glycero-3-PC
|
|
|
|
1-Stearoyl-2-docosahexaenoyl-sn-glycero-3-PC is a phospholipid in biological membranes containing stearic acid and docosahexaenoic acid at the sn-1 and sn-2 positions, respectively. It has been used to study the organiza... |
|
TP2117 |
SAHM1
|
|
|
|
Notch pathway inhibitor - stabilized hydrocarbon-stapled alpha helical peptide. Targets the protein-protein interface and prevents Notch complex assembly. |
|
T36105 |
Coumarin-SAHA
|
coumarin-Suberoylanilide Hydroxamic Acid,coumarin-SAHA |
|
|
Suberoylanilide hydroxamic acid (SAHA) is a class I and class II histone deacetylase (HDAC) inhibitor that binds directly to the catalytic site of the enzyme thereby blocking substrate access. [1] coumarin-Suberoylanili... |
|
T35766 |
SAHO
|
|
|
|
SAHO is a sulfoxide form of the methyl donor S-(5'-adenosyl)-L-methionine chloride and a substrate for radical SAM enzymes.1It is reductively cleaved to S-adenosylhomocysteine , 5'-deoxyadenosine , and 5'-thioadenosine s... |
|
T19556 |
SAHA chloroalkane T1
|
|
Others
|
|
SAHA chloroalkane T1 is a novel compound formed by combining Vorinostat (SAHA) with a chloroalkane capture tag, referred to as T1. This innovative approach involves tethering the SAHA molecule with the T1 tag, resulting ... |
|
T37633 |
17-oxo-4(Z),7(Z),10(Z),13(Z),15(E),19(Z)-Docosahexaenoic Acid
|
|
|
|
17-oxo-4(Z),7(Z),10(Z),13(Z),15(E),19(Z)-Docosahexaenoic acid is a metabolite of lipoxygenase-mediated oxidation of DHA that is produced endogenously by aspirin-enhanced COX-2 activity. It has been shown to activate Nrf2... |
|
T74764 |
Adenosylhomocysteinase
|
|
|
|
Adenosylhomocysteinase (SAHH; AHCY), a highly conserved enzyme, reversibly catalyzes S-adenosylhomocysteine (SAH) into adenosine and L-homocysteine. Its level in serum exosomes serves as a prognostic biomarker for HBV-LC... |
|
T70186 |
Methazolamide-d6
|
|
|
|
Methazolamide-d6 is intended for use as an internal standard for the quantification of methazolamide by GC- or LC-MS. Methazolamide is a carbonic anhydrase inhibitor. It reduces intraocular pressure and cerebrospinal flu... |
